View Older Stories View More Recent Stories

Nov 13, 2025 09:03AM Form SCHEDULE 13G Talon Capital Corp. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:03AM Form SCHEDULE 13G/A BridgeBio Oncology Thera Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:03AM Form SCHEDULE 13G Galata Acquisition Corp. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:02AM Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:02AM Form SCHEDULE 13G NORTHPOINTE BANCSHARES Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:01AM Form SCHEDULE 13G Highview Merger Corp. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:01AM Form SCHEDULE 13G MONRO, INC. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:00AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:00AM Form SCHEDULE 13G BRIGHT MINDS BIOSCIENCES Filed by: Adage Capital Management, L.P.
Nov 3, 2025 04:10PM Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Adage Capital Management, L.P.
Oct 31, 2025 04:19PM Cybin completes $175 million stock offering
Oct 31, 2025 04:19PM Cybin Announces Closing of $175 Million Registered Direct Offering
Oct 31, 2025 10:42AM Form SCHEDULE 13D/A 89bio, Inc. Filed by: Adage Capital Management, L.P.
Oct 28, 2025 08:00AM Cybin raises $175 million in registered direct offering
Oct 28, 2025 08:00AM Cybin Announces $175 Million Registered Direct Offering
Oct 23, 2025 07:25AM Tango Therapeutics raises $225 million in stock offering
Oct 23, 2025 07:20AM Tango Therapeutics Announces $225 Million Financing
Oct 14, 2025 06:30AM Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
Oct 3, 2025 04:01PM Form SCHEDULE 13D 89bio, Inc. Filed by: Adage Capital Management, L.P.
Oct 2, 2025 04:05PM Palisade Bio closes $138 million public offering to fund drug trial
Oct 2, 2025 04:05PM Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option
Sep 11, 2025 10:57AM UNCF Announces Dr. Shawn Thomas as Director of Investment Leadership Programs and Lead for Project ACCLAIM
Sep 10, 2025 07:00AM CAMP4 raises up to $100 million for SYNGAP1 disorder treatment
Sep 10, 2025 07:00AM CAMP4 raises up to $100 million for SYNGAP1 disorder treatment
Sep 10, 2025 07:00AM CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
Sep 10, 2025 07:00AM PsiQuantum Raises $1 Billion to Build Million-Qubit Scale, Fault-Tolerant Quantum Computers
Sep 2, 2025 04:07PM Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Adage Capital Management, L.P.
Aug 29, 2025 12:34PM Form N-PX ADAGE CAPITAL PARTNERS For: Jun 30
Aug 29, 2025 12:34PM Form N-PX Adage Capital Management For: Jun 30
Aug 25, 2025 07:00AM iBio closes $50 million public offering led by Balyasny
Aug 25, 2025 07:00AM iBio Announces Closing of $50 Million Public Offering
Aug 20, 2025 07:00AM I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update
Aug 14, 2025 09:05AM Form 13F-NT Adage Capital Management For: Jun 30
Aug 14, 2025 09:04AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Jun 30
Aug 12, 2025 09:07AM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:07AM Form SCHEDULE 13G/A TScan Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:07AM Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:07AM Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G DBV Technologies S.A. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G Adagio Medical Holdings, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G/A IMMUNIC, INC. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:05AM Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:05AM Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:04AM Form SCHEDULE 13G/A ProQR Therapeutics N.V. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:04AM Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:04AM Form SCHEDULE 13G/A Seadrill Ltd Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:03AM Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:03AM Form SCHEDULE 13G/A Ensysce Biosciences, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:02AM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Adage Capital Management, L.P.
View More Recent Stories View Older Stories